超越基因型:聚类分析揭示儿童家族性地中海热临床异质性
该单中心回顾性研究纳入185例依据Eurofever标准诊断的儿童家族性地中海热(FMF)患者,采用聚类分析识别出五个临床亚组,从无需治疗的无症状或轻度杂合子到早发重症纯合子。研究发现基因型不能完全解释临床变异,部分杂合子患者病程并不轻微。
要点
- 儿童FMF聚类分析识别出五个临床亚组,疾病表现异质。
- 杂合子患者总体病情较轻,但并非全部呈轻度病程。
- 女性早发M694V纯合子患者富集于重症表型。
核心结论
- 聚类分析识别出儿童FMF异质的疾病表达模式,提示基因型本身不能完全解释临床变异。
研究设计与样本
- 单中心回顾性研究纳入2004至2025年依据Eurofever标准诊断的185例儿童FMF患者,按遗传确诊(纯合或复合杂合)与症状性杂合子分层,纵向收集数据并用聚类分析识别亚组。
主要发现
- 与遗传确诊FMF相比,杂合子病情更轻、秋水仙碱剂量更低且IL-1抑制剂使用更少。
- 聚类分析识别出五个不同亚组,从无需治疗的无症状或轻度杂合子到需高剂量秋水仙碱和IL-1抑制剂的早发重症纯合子。
- 并非所有杂合子患者均为轻度病程。
- 性别、起病年龄、基因型、发作频率和炎症标志物参与亚组区分,重症表型富集于女性早发M694V纯合子患者。
临床怎么用
- 临床评估FMF患儿时应结合基因型以外的多维临床特征进行分层管理。
- 对症状性杂合子不应默认病情轻微,需个体化评估和治疗。
- 女性早发M694V纯合子患者应警惕重症表型,可能需要更高强度治疗。
局限性
- 单中心回顾性设计可能限制结果外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Familial Mediterranean fever (FMF) is an autoinflammatory disease caused by mutations in the MEFV gene. Despite therapeutic advances with colchicine and interleukin-1 (IL-1) inhibitors, FMF shows marked interindividual variability, including among symptomatic heterozygotes, challenging genotype-phenotype correlations. OBJECTIVES: To identify clinically meaningful subgroups of paediatric patients with FMF using a clustering approach and to characterise their clinical features and disease trajectories. METHODS: We conducted a monocentric retrospective study including 185 paediatric patients diagnosed with FMF between 2004 and 2025 according to Eurofever criteria. Patients were stratified as genetically confirmed FMF (homozygous, compound heterozygous) or symptomatic heterozygotes. Demographic, clinical, laboratory and treatment data were collected longitudinally. Clustering analysis was used to identify clinically meaningful subgroups. RESULTS: The median age at onset was 2.5 years and the median diagnostic delay was 24 months. Ninety-three (50%) patients were symptomatic heterozygotes. Compared with genetically confirmed FMF, heterozygotes had milder disease, lower colchicine doses and less frequent IL-1 inhibitor use. Cluster analysis identified five distinct subgroups, ranging from asymptomatic or mild heterozygotes without treatment to early-onset homozygous patients with severe disease requiring higher-dose colchicine and IL-1 inhibitors. Not all heterozygous patients had a mild disease course. Sex, age at onset, genotype, attack frequency and inflammatory markers contributed to cluster differentiation. Severe phenotypes were enriched in female patients with early-onset M694V homozygosity. CONCLUSION: Cluster analysis identified heterogeneous patterns of disease expression, suggesting that the genotype alone does not fully explain clinical variability in FMF. These findings highlight the value of multidimensional approaches to better characterise disease heterogeneity.
引用
- Mahé I, Billard C, Anselmi F, et al. Beyond genotype: clustering analysis highlights clinical heterogeneity in paediatric familial Mediterranean fever. RMD Open. 2026. PMID: 42399078. doi:10.1136/rmdopen-2026-006764
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。